TF and cancer: This finding provides compelling in vivo evidence supporting ZEB1 as a core EMT-TF [4, 6], aligning with previous research highlighting enriched EMT features in TNBC cancer cells expressing Vim [35, 36] and linking EMT features with ZEB1 expression in tumor budding [31].